FDA stands for the United States Food and Drug Administration and is a major agency in the Department of Health & Human Services. Originally formed in 1906, the FDA has expanded into a functional agency that is responsible for the safeguarding of the consumer interests of food, drugs, medical devices and many others.(1)
The FDAs mission is to ensure that the drug products are protected in as far as quality, safety & efficacy of human and animal drugs and biologics; medical devices; the food supply; cosmetics; and products that emit radiation are concerned. It also has a crucial role in fighting to guard foods as well as to build up medical products regarding public health threats.(2)
The fiscal year 2025 budget allocation for FDA is USD 7.2 billion. This budget funds an overall increase of 7.4% or USD 495 million above the enacted FY 2023 funding level. The increase is for funding for improvements in food safety for medical product safety, capacity for public health, and improvement of FDA’s infrastructure.(3)
In this case, the FDA plays pivotal roles in the process of approving drugs to enhance safety effectiveness and quality of the drugs used in the market. It starts with the preclinical phase and IND, then clinical trials in three phases. New Drug Application (NDA) is filed with FDA following positive results from trial hearings, and the FDA examines all collected data before granting newer drugs approval for common use.
After approval, the FDA track drugs through post-market surveillance, adverse event, reporting, risk management plans and actions if there is a need to. The agency also allows early approval to narrow therapeutic index products through the Food and Drug Administration Modernization Act’s fast track, breakthrough therapy, and accelerated approval processes. This careful balance of speed and safety rate promises that patient can count on approved drugs while at the same time avoiding any type of risk. FDA’s broad ranging surveillance ensures the public’s health safety while at the same time encouraging the pharmaceutical business.
The FDA serves an important function to the pharma business by inspecting drug and medical device products to make sure they are secure and effective for use. This takes a number of years and require preclinical approval, clinical approval, and post market approval(2). The FDA has very strict normative requirements helping to maintain high levels of compliance with the requirements of drug development, so that the pharmaceutical industry complied with the norms of Good Manufacturing Practices (GMP) and other requirements for safety.
On recent years, FDA has persisted in updating its self and new difficulties and developments in the pharma industry. These are in matters of regulating new policies for the healthcare system, recognition and approval of new techniques and treatments as well as addressing public health crises as COVID-19.(4)
By making rules that dictate standards for product quality, manufacturing, safety, usage or distribution. FDA also affects those from other countries around the world in the following ways. However, below is a brief highlight of how the FDA influences international pharmaceutical system practices.:
The FDA collaborates with other international agencies with a view of achieving more convergence among the various agencies. This is achieved through such agencies as ICH. Hence the collaboration assists in cutting out redundant practice such as re- running of clinical trials and ensuring that laid down safety and Efficacy standards are met.(5)
Most countries use the benchmark from FDA when establishing their requirements for regulating the industry. This means that getting a drug adopted in the United States through FDA approval will increase the likelihood of its approval by other countries thereby making it easier to venture into worldwide distribution of new treatments.(5)
The agency’s set quality standards for manufacturing and testing in most cases act as reference that is adopted in other countries that have similar quality standards.(5)
It is clearly seen that the FDA has a large impact on the Indian Pharmaceutical Industry as it promotes compliance, quality, innovation and economic development. This relationship helps both nations by guaranteeing access of high quality; cheaper medicines to patients around the globe. Several consequences follow from FDA’s influence over the Indian pharmaceutical commerce and manufacturing: -
India’s pharma industries have to adhere to the FDA rules if they wish to sell their drugs in the United States. This entails following high quality standard, GMP and constant monitoring by FDA. Requisite means that the drugs manufactured in India meet strict safety and quality standard that the FDA demands.(6)
This permission is vital for the Indian drug producers as the United States is regarded to be one of the most attractive markets for most producers. Most Indian companies have developed FDA compliant manufacturing depots in the USA due to compliance-wall issue to enter the market. (6)
India is World’s largest supplier of generic drugs to the United States supplying cheap medicines making substantial contribution to the supply chain of medicines to the world. The industry needs FDA compliance for export and partnership, which is seen to foster the growth of the industry.(7)
The agency delegates to the FDA an inventive and pivotal assignment of safeguarding the public health in relation to pharmaceutical products. This blog aims to argue that despite the changes in regulations and economies the FDA remains relevant, effective and continues to safeguards consumers while promoting innovation for pharmaceutical industries.
References